Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics
Lisa Brockhaus, David Goldblum, Laura Eggenschwiler, et al.
Clinical Microbiology and Infection (2019) Vol. 25, Iss. 11, pp. 1364-1369
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Clarithromycin Solid Lipid Nanoparticles for Topical Ocular Therapy: Optimization, Evaluation and In Vivo Studies
Anroop B. Nair, Jigar Shah, Bandar E. Al‐Dhubiab, et al.
Pharmaceutics (2021) Vol. 13, Iss. 4, pp. 523-523
Open Access | Times Cited: 77
Complications of intravitreal injections: 2022
Dillan Patel, Samir Patel, Varun Chaudhary, et al.
Current Opinion in Ophthalmology (2022) Vol. 33, Iss. 3, pp. 137-146
Closed Access | Times Cited: 51
A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances
Rui Wang, Yuan Gao, Anchang Liu, et al.
Journal of drug targeting (2021) Vol. 29, Iss. 7, pp. 687-702
Closed Access | Times Cited: 54
Integrative metabolomics and transcriptomics identifies itaconate as an adjunct therapy to treat ocular bacterial infection
Sukhvinder Singh, Pawan Kumar Singh, Alokkumar Jha, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 5, pp. 100277-100277
Open Access | Times Cited: 44
Bacteria-Targeting Nanoparticles with ROS-Responsive Antibiotic Release to Eradicate Biofilms and Drug-Resistant Bacteria in Endophthalmitis
Jian Yu, Huan Xu, Jiaojiao Wei, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2939-2956
Open Access | Times Cited: 6
The Role of Systemic Antimicrobials in the Treatment of Endophthalmitis: A Review and an International Perspective
Andrzej Grzybowski, Magdalena Turczynowska, Stephen G. Schwartz, et al.
Ophthalmology and Therapy (2020) Vol. 9, Iss. 3, pp. 485-498
Open Access | Times Cited: 40
Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Ocular Infections
Sixto M. Leal, Kyle G. Rodino, W. C. Fowler, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 3
Open Access | Times Cited: 40
Uveítis infecciosa: epidemiología, etiología, rendimiento de pruebas diagnósticas y tratamiento
L.M. Méndez-Rodríguez, Laura Cristina Nócua-Báez, Germán Mejía‐Salgado, et al.
Archivos de la Sociedad Española de Oftalmología (2025)
Closed Access
The latest updates on the proper use of fluoroquinolones – Actualisation 2025 update by the SPILF and the GPIP
Fanny Vuotto, J.P. Bru, E Canaoui, et al.
Infectious Diseases Now (2025), pp. 105062-105062
Closed Access
<p>Complete and Early Vitrectomy for Endophthalmitis After Cataract Surgery: An Alternative Treatment Paradigm</p>
Bernard Dib, Robert E. Morris, Matthew H. Oltmanns, et al.
Clinical ophthalmology (2020) Vol. Volume 14, pp. 1945-1954
Open Access | Times Cited: 38
Endogenous Endophthalmitis—The Clinical Significance of the Primary Source of Infection
Małgorzata Gajdzis, Kornelia Figuła, Joanna Kamińska, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 5, pp. 1183-1183
Open Access | Times Cited: 19
Clinical Characteristics, Pathogen Distribution, and Factors Affecting Visual Outcomes of Pediatric Post-Traumatic Endophthalmitis
Xiaoxia Li, Yibin Zhou, Zhi Chen, et al.
Antibiotics (2025) Vol. 14, Iss. 1, pp. 20-20
Open Access
Controversies in the management of endophthalmitis: a 5-year retrospective cohort study
Ohisa Harley, Yufilia Suci Amelia, Elsa Gustianty, et al.
Journal of Ophthalmic Inflammation and Infection (2025) Vol. 15, Iss. 1
Open Access
Rare and in Your Chair: An Emerging Use of Meropenem in a Case of Klebsiella pneumoniae Endophthalmitis Following Cataract Surgery
Shu Chyi Ong, Sruban Suparmaniam
Cureus (2025)
Open Access
Endogenous Endophthalmitis - A Major Review
Cen Amy Xie, Jayanti Singh, Mudit Tyagi, et al.
Ocular Immunology and Inflammation (2022) Vol. 31, Iss. 7, pp. 1362-1385
Closed Access | Times Cited: 17
Preventive factors, diagnosis, and management of injection-related endophthalmitis: a literature review
Rupali Singh, Samaneh Davoudi, Steven Ness
Graefe s Archive for Clinical and Experimental Ophthalmology (2022)
Open Access | Times Cited: 16
Sequential drug release of co-assembled supramolecular hydrogel as synergistic therapy against Staphylococcus aureus endophthalmitis
Ailing Yu, Yuhan Hu, Xiaohui Ma, et al.
Chemical Engineering Journal (2021) Vol. 427, pp. 130979-130979
Closed Access | Times Cited: 22
Pathobiology of Aspergillus Fumigatus Endophthalmitis in Immunocompetent and Immunocompromised Mice
Neha Gupta, Pawan Kumar Singh, Sanjay G. Revankar, et al.
Microorganisms (2019) Vol. 7, Iss. 9, pp. 297-297
Open Access | Times Cited: 25
Clinical profile and outcome of endogenous endophthalmitis at a quaternary referral centre in south India
KiranKrishnankutty Remadevi, GopalS Pillai, V Anilkumar, et al.
Indian Journal of Ophthalmology (2020) Vol. 68, Iss. 5, pp. 827-827
Open Access | Times Cited: 22
Clinical Insights: Antimicrobial Therapy for Infectious Uveitis
Evangeline Leong, Carlos Cifuentes‐González, Jeremy Hu Y. W., et al.
Ocular Immunology and Inflammation (2024), pp. 1-21
Closed Access | Times Cited: 2
Endogenous endophthalmitis: New insights from a 12-year cohort study
Daphné Dedieu, Adrien Contejean, Nabil Gastli, et al.
International Journal of Infectious Diseases (2024) Vol. 146, pp. 107116-107116
Closed Access | Times Cited: 2
Do Treatment Patterns for Endophthalmitis after Cataract Surgery Follow the Endophthalmitis Vitrectomy Study Recommendations?
Maurizio Tomaiuolo, Jordan D. Deaner, Brian L. VanderBeek, et al.
Ophthalmology Retina (2024) Vol. 8, Iss. 11, pp. 1035-1043
Closed Access | Times Cited: 2
Comprehensive Pharmacokinetic Evaluation of High Melanin Binder Levofloxacin in Rabbits Shows Potential of Topical Eye Drops for Posterior Segment Treatment
Sina Bahrpeyma, Paulina Jakubiak, Rubén Alvarez‐Sánchez, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 12, pp. 14-14
Open Access | Times Cited: 2
Does Endogenous Endophthalmitis Need a More Aggressive Treatment?
Sara Spelta, Antonio Di Zazzo, Marco Antonini, et al.
Ocular Immunology and Inflammation (2020) Vol. 29, Iss. 5, pp. 937-943
Closed Access | Times Cited: 20
A Review of Ocular Drug Delivery Platforms and Drugs for Infectious and Noninfectious Uveitis: The Past, Present, and Future
Christopher D. Conrady, Steven Yeh
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1224-1224
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top